z-logo
open-access-imgOpen Access
Low rate of subsequent malignant neoplasms after CD19 CAR T-cell therapy
Author(s) -
Emily M. Hsieh,
Regina M. Myers,
Bonnie Yates,
Colleen Annesley,
Samuel John,
Agne Taraseviciute,
Seth M. Steinberg,
Jennifer Sheppard,
Perry Chung,
Lee Chen,
Daniel W. Lee,
Amanda M. DiNofia,
Stephan A. Grupp,
Michael R. Verneris,
Theodore W. Laetsch,
Deepa Bhojwani,
Patrick A. Brown,
Michael A. Pulsipher,
Susan R. Rheingold,
Rebecca Gardner,
Lia Gore,
Nirali N. Shah,
Adam J. Lamble
Publication year - 2022
Publication title -
blood advances
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.685
H-Index - 39
eISSN - 2473-9537
pISSN - 2473-9529
DOI - 10.1182/bloodadvances.2022008093
Subject(s) - cumulative incidence , medicine , oncology , incidence (geometry) , cancer , disease , cd19 , pediatric cancer , childhood cancer , immune system , immunology , pediatrics , transplantation , physics , optics

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom